Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SRTA · against 557 other Healthcare companies listed in US-listed
Ranked #202 of 558 · scores higher than 63% of peers
Bars: peers in each 10-point band of the profitability score34 peers with a profitability score of 40–49, including SRTA · Click a bar to see the companies
A mix: stronger return on assets, but weaker operating margin and return on invested capital than most Healthcare peers.
| Metric | SRTA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -6.1% | -7.0% | 51% | 33% | |
| Operating marginHigher is better · 479 reported | -8.0% | -2.4% | 44% | 33% | |
| Return on assetsHigher is better · 582 reported | 12.1% | -7.8% | 89% | 33% | |
| Return on equityHigher is better · 531 reported | -9.2% | -19.7% | 57% | Context only | |
| Gross marginHigher is better · 601 reported | 21.3% | 43.9% | 39% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 622M USD | 99 | 97 | |
| 1 | 441M USD | 99 | 81 | |
| 1 | 18.0B USD | 99 | 76 | |
| 1 | 623M USD | 99 | 73 | |
| 1 | 4.2B USD | 99 | 70 | |
| 197 | 10.1B USD | 46 | 61 | |
| 201 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 1.7B USD |
| 45 |
| 52 |
| 202 | 102.3B USD | 44 | 48 |
| 202 | 818M USD | 44 | 54 |
| 202 | 462M USD | 44 | 60 |
| 202 | 1.4B USD | 44 | 58 |
| 206 | 45.9B USD | 43 | 46 |
| 207 | 3.3B USD | 42 | 52 |
| 207 | 1.2B USD | 42 | 43 |